Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
Baden, Lindsey R, El Sahly, Hana M, Essink, Brandon, Kotloff, Karen, Frey, Sharon, Novak, Rick, Diemert, David, Spector, Stephen A, Rouphael, Nadine, Creech, C. Buddy, McGettigan, John, Khetan, Shishir, Segall, Nathan, Solis, Joel, Brosz, Adam, Fierro, Carlos, Schwartz, Howard, Neuzil, Kathleen, Corey, Larry, Gilbert, Peter, Janes, Holly, Follmann, Dean, Marovich, Mary, Mascola, John, Polakowski, Laura, Ledgerwood, Julie, Graham, Barney S, Bennett, Hamilton, Pajon, Rolando, Knightly, Conor, Leav, Brett, Deng, Weiping, Zhou, Honghong, Han, Shu, Ivarsson, Melanie, Miller, Jacqueline, Zaks, Tal
Published in New England Journal of Medicine (04.02.2021)
Published in New England Journal of Medicine (04.02.2021)
Get full text
Journal Article
Web Resource
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses
Bahl, Kapil, Senn, Joe J., Yuzhakov, Olga, Bulychev, Alex, Brito, Luis A., Hassett, Kimberly J., Laska, Michael E., Smith, Mike, Almarsson, Örn, Thompson, James, Ribeiro, Amilcar (Mick), Watson, Mike, Zaks, Tal, Ciaramella, Giuseppe
Published in Molecular therapy (07.06.2017)
Published in Molecular therapy (07.06.2017)
Get full text
Journal Article
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials
Feldman, Robert A., Fuhr, Rainard, Smolenov, Igor, (Mick) Ribeiro, Amilcar, Panther, Lori, Watson, Mike, Senn, Joseph J., Smith, Mike, Almarsson, Ӧrn, Pujar, Hari S., Laska, Michael E., Thompson, James, Zaks, Tal, Ciaramella, Giuseppe
Published in Vaccine (31.05.2019)
Published in Vaccine (31.05.2019)
Get full text
Journal Article
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
August, Allison, Attarwala, Husain Z., Himansu, Sunny, Kalidindi, Shiva, Lu, Sophia, Pajon, Rolando, Han, Shu, Lecerf, Jean-Michel, Tomassini, Joanne E., Hard, Marjie, Ptaszek, Leon M., Crowe, James E., Zaks, Tal
Published in Nature medicine (01.12.2021)
Published in Nature medicine (01.12.2021)
Get full text
Journal Article
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer
Massarweh, Amir, Eliakim-Raz, Noa, Stemmer, Amos, Levy-Barda, Adva, Yust-Katz, Shlomit, Zer, Alona, Benouaich-Amiel, Alexandra, Ben-Zvi, Haim, Moskovits, Neta, Brenner, Baruch, Bishara, Jihad, Yahav, Dafna, Tadmor, Boaz, Zaks, Tal, Stemmer, Salomon M
Published in JAMA oncology (01.08.2021)
Published in JAMA oncology (01.08.2021)
Get more information
Journal Article
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults
Aliprantis, Antonios O., Shaw, Christine A., Griffin, Paul, Farinola, Nicholas, Railkar, Radha A., Cao, Xin, Liu, Wen, Sachs, Jeffrey R., Swenson, Christine J., Lee, Heather, Cox, Kara S., Spellman, Daniel S., Winstead, Colleen J., Smolenov, Igor, Lai, Eseng, Zaks, Tal, Espeseth, Amy S., Panther, Lori
Published in Human vaccines & immunotherapeutics (04.05.2021)
Published in Human vaccines & immunotherapeutics (04.05.2021)
Get full text
Journal Article
Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
FAWN QIAN, ENGST, Stefan, LOUGHEED, Julie, YAKSE, F. Michael, BENTZIEN, Frauke, WEI XU, ZAKS, Tal, WOOSTER, Richard, GRESHOCK, Joel, JOLY, Alison H, YAMAGUCHI, Kyoko, PEIWEN YU, WON, Kwang-Ai, MOCK, Lillian, LOU, Tracy, TAN, Jenny, CONNIE LI, TAM, Danny
Published in Cancer research (Chicago, Ill.) (15.10.2009)
Published in Cancer research (Chicago, Ill.) (15.10.2009)
Get full text
Journal Article
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus
August, Allison, Attarwala, Husain Z., Himansu, Sunny, Kalidindi, Shiva, Lu, Sophia, Pajon, Rolando, Han, Shu, Lecerf, Jean-Michel, Tomassini, Joanne E., Hard, Marjie, Ptaszek, Leon M., Crowe, James E., Zaks, Tal
Published in Nature medicine (01.05.2022)
Published in Nature medicine (01.05.2022)
Get full text
Journal Article
Phase II Study of Predictive Biomarker Profiles for Response Targeting Human Epidermal Growth Factor Receptor 2 (HER-2) in Advanced Inflammatory Breast Cancer With Lapatinib Monotherapy
JOHNSTON, Stephen, TRUDEAU, Maureen, HARRIS, Jennifer, WESTLUND, Ron E, SALAZAR, Vanessa, ZAKS, Tal Z, SPECTOR, Neil L, KAUFMAN, Bella, BOUSSEN, Hamouda, BLACKWELL, Kimberley, LORUSSO, Patricia, LOMBARDI, Donald P, AHMED, Slim Ben, CITRIN, Dennis L, DESILVIO, Michelle L
Published in Journal of clinical oncology (01.03.2008)
Published in Journal of clinical oncology (01.03.2008)
Get full text
Journal Article
High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization
Naylor, Tara L, Greshock, Joel, Wang, Yan, Colligon, Theresa, Yu, Q C, Clemmer, Virginia, Zaks, Tal Z, Weber, Barbara L
Published in Breast cancer research : BCR (01.01.2005)
Published in Breast cancer research : BCR (01.01.2005)
Get full text
Journal Article
Phase II Study to Evaluate the Efficacy and Safety of Neoadjuvant Lapatinib Plus Paclitaxel in Patients With Inflammatory Breast Cancer
BOUSSEN, Hamouda, CRISTOFANILLI, Massimo, ZAKS, Tal, DESILVIO, Michelle, SALAZAR, Vanessa, SPECTOR, Neil
Published in Journal of clinical oncology (10.07.2010)
Published in Journal of clinical oncology (10.07.2010)
Get full text
Journal Article
Randomized Phase II Multicenter Trial of Two Schedules of Lapatinib as First- or Second-Line Monotherapy in Patients with Advanced or Metastatic Non-Small Cell Lung Cancer
ROSS, Helen J, BLUMENSCHEIN, George R, LEOPOLD, Lance, ZAKS, Tal Z, SHEPHERD, Frances A, AISNER, Joseph, DAMJANOV, Nevena, DOWLATI, Afshin, GARST, Jennifer, RIGAS, James R, SMYLIE, Michael, HASSANI, Habib, ALLEN, Kimberly E
Published in Clinical cancer research (15.03.2010)
Published in Clinical cancer research (15.03.2010)
Get full text
Journal Article
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study
Kaufman, Bella, Dr, Trudeau, Maureen, Prof, Awada, Ahmad, Prof, Blackwell, Kimberly, MD, Bachelot, Thomas, MD, Salazar, Vanessa, BS, DeSilvio, Michelle, PhD, Westlund, Ronald, MS, Zaks, Tal, MD, Spector, Neil, MD, Johnston, Stephen, MD
Published in The lancet oncology (01.06.2009)
Published in The lancet oncology (01.06.2009)
Get full text
Journal Article
Cancer cell lines as genetic models of their parent histology : Analyses based on array comparative genomic hybridization
GRESHOCK, Joel, NATHANSON, Katherine, MARTIN, Anne-Marie, LIN ZHANG, COUKOS, George, WEBER, Barbara L, ZAKS, Tal Z
Published in Cancer research (Chicago, Ill.) (15.04.2007)
Published in Cancer research (Chicago, Ill.) (15.04.2007)
Get full text
Journal Article
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors
Galsky, Matthew D., Von Hoff, Daniel D., Neubauer, Marcus, Anderson, Thomas, Fleming, Mark, Nagarwala, Yasir, Mahoney, Janine M., Midwinter, Dawn, Vocila, Linda, Zaks, Tal Z.
Published in Investigational new drugs (01.04.2012)
Published in Investigational new drugs (01.04.2012)
Get full text
Journal Article
Cancer therapy using a self-replicating RNA vaccine
Restifo, Nicholas P, Ying, Han, Zaks, Tal Z, Wang, Rong-Fu, Irvine, Kari R, Kammula, Udai S, Marincola, Francesco M, Leitner, Wolfgang W
Published in Nature medicine (01.07.1999)
Published in Nature medicine (01.07.1999)
Get full text
Journal Article
Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines
Greshock, Joel, Cheng, Jie, Rusnak, David, Martin, Anne Marie, Wooster, Richard, Gilmer, Tona, Lee, Kwan, Weber, Barbara L, Zaks, Tal
Published in Molecular cancer therapeutics (01.04.2008)
Published in Molecular cancer therapeutics (01.04.2008)
Get full text
Journal Article